Research News

Jason benedict looking at a crystal.
  • Crystals in a new light
    2/12/26

    A setback in growing light-responsive crystals led UB chemist Jason Benedict and his team to a novel method for mapping molecular arrangements.

  • Fliesler recognized for retina research
    12/5/22

    The SUNY Distinguished Professor has been named the 2022 recipient of the Retina Research Foundation’s Paul Kayser International Award in Retina Research.

  • An alternative method to map neuron activity
    12/2/22

    A  paper published recently by UB mathematicians suggests that “hypergraphs” 
    better explain how neuronal networks communicate.

  • Local teens with obesity see dramatic weight loss in trial
    12/2/22

    The results of a UB clinical trial on the drug semaglutide turned out to be better than anything the participants — or researchers — expected.

  • Study examines pre-quit time of smoking cessation drug
    12/1/22

    A UB-led study found that extending the pre-quit duration of a leading smoking cessation medication doesn’t help smokers quit.

  • Company addressing opioid issue with tech licensed from UB
    12/1/22

    Channavix Therapeutics and Peregrine BioVentures are developing patent families related to long-lasting, non-addictive pain therapeutics.

  • RSV, flu, COVID in kids
    11/29/22

    Infectious disease expert Oscar G. Gómez-Duarte talks with UBNow about the alarming surge in these viruses among kids and what parents can do to keep them healthy.

  • UB joins I-Corps Hub
    11/29/22

    The $15 million NSF program, based at Cornell, will foster innovation and accelerate economic development in Western New York.

  • Gore addresses intentional violence as public health issue
    11/23/22

    The Jacobs School alumnus was the keynote speaker for the Community Health Equity Research Institute’s annual research day.

  • Monitoring air pollution on Buffalo’s East Side
    11/23/22

    The EPA initiative aims to improve health outcomes in neighborhoods whose residents are more likely to suffer chronic, serious diseases.

  • Adapting concussion treatment to military
    11/18/22

    UB researchers have received a $4.8 million federal grant to launch a clinical trial that will take their protocol for treating concussed athletes and apply it to the military environment.